Arrowhead Pharmaceuticals Inc (ARWR)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-12 | Dr. Hongbo LuIndependent Director | -2.97k | 228.33k | 売り | 76.88 | 41.82k | -6.63% |
| 2026-04-22 | Mr. Daniel J. ApelCFO | -13.10k | 934.29k | Automatic Disposition | 70.11 - 71.92 | 12.91k | -50.37% |
| 2026-04-23 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -10.00k | 750.00k | Automatic Disposition | 75.00 | 226.96k | -4.22% |
| 2026-03-05 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -10.00k | 641.90k | Automatic Disposition | 64.19 | 236.96k | -4.05% |
| 2026-01-06 | Mr. Patrick O'BrienCOO & Secretary | -2.50k | 0.00 | Other Disposition | - | 263.66k | -0.94% |
| 2026-01-05 | Mr. Patrick O'BrienCOO & Secretary | -49.49k | 3.12M | Automatic Disposition | 61.12 - 68.00 | 341.16k | -12.67% |
| 2025-12-31 | Mr. Patrick O'BrienCOO & Secretary | -2.80k | 0.00 | Other Disposition | - | 341.16k | -0.81% |
| 2026-01-05 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -40.16k | 2.53M | Automatic Disposition | 61.24 - 68.00 | 171.96k | -18.93% |
| 2026-01-02 | Dr. Christopher R. AnzaloneChairman, CEO & President | -13.19k | 871.70k | Automatic Disposition | 65.88 - 66.39 | 3.79M | -0.35% |
| 2025-12-29 | Dr. Christopher R. AnzaloneChairman, CEO & President | -51.73k | 3.26M | Derivative Exercise and Sale | 6.15 - 69.33 | 3.81M | - |
| 2025-12-26 | Dr. Mauro FerrariIndependent Director | -7.53k | 527.10k | Automatic Disposition | 70.00 | 61.23k | -10.95% |
| 2025-12-19 | Dr. Christopher R. AnzaloneChairman, CEO & President | -26.03k | 1.77M | Automatic Disposition | 66.67 - 68.85 | 3.81M | -0.68% |
| 2025-12-19 | Ms. Victoria M. VakienerIndependent Director | -10.04k | 679.49k | Automatic Disposition | 66.63 - 68.39 | 27.90k | -26.46% |
| 2025-12-19 | Mr. William D. WaddillIndependent Lead Director | -8.37k | 566.04k | Automatic Disposition | 66.66 - 68.53 | 48.74k | -14.65% |
| 2025-12-19 | Dr. Adeoye Y. OlukotunIndependent Director | -10.00k | 676.62k | Automatic Disposition | 66.70 - 68.48 | 33.60k | -22.94% |
| 2025-12-17 | Dr. Christopher R. AnzaloneChairman, CEO & President | -85.00k | 5.44M | 売り | 63.55 - 66.30 | 3.83M | -2.17% |
| 2025-12-15 | Dr. Christopher R. AnzaloneChairman, CEO & President | -184.30k | 12.35M | 売り | 60.51 - 69.96 | 3.92M | -4.49% |
| 2025-12-05 | Dr. Michael Steven PerryIndependent Director | -16.25k | 991.74k | 売り | 61.03 | 98.51k | -14.16% |
| 2025-11-28 | Dr. Mauro FerrariIndependent Director | -8.75k | 493.41k | 売り | 56.39 | 52.03k | -14.40% |
| 2025-10-01 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -20.00k | 700.00k | Automatic Disposition | 35.00 | 212.12k | -8.62% |
| 2025-09-12 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -15.00k | 450.00k | Automatic Disposition | 30.00 | 232.12k | -6.07% |
| 2025-09-02 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -15.00k | 375.00k | Automatic Disposition | 25.00 | 247.12k | -5.72% |
| 2025-08-13 | Dr. James C. HamiltonChief Medical Officer and Head of R&D | -10.00k | 200.00k | Automatic Disposition | 20.00 | 262.12k | -3.67% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。